SRC and cancer: These observations strongly suggest that “the p17 protein suppresses TKs5 phosphorylation in cancer cells through suppression of Src activity.” By modulating this pathway, p17 effectively limits TKs5 activation, which is crucial for invadopodia formation and cell migration.